TempraMed expands TEM Consulting distribution partnership across Latin America beyond Panama

TempraMed Technologies amended its exclusive distribution agreement with TEM Consulting International to expand beyond Panama into Argentina, Venezuela, Colombia, Costa Rica. Scope broadened to include VIVI Med, alongside VIVI Cap and VIVI Epi, extending the portfolio beyond insulin pens. TEM placed an additional commercial order expected to be fulfilled by end-September 2026. Combined with separate Mexico, Brazil initiatives, distribution coverage is expected to reach seven Latin American countries once registrations are completed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempramed Technologies Ltd. published the original content used to generate this news brief via (Ref. ID: 202609240255NEWSFILECNPR____20260924_315793_1) on September 24, 2026, and is solely responsible for the information contained therein. (C)